Literature DB >> 17987591

Expectations of general practitioners and specialist doctors regarding the feedback received after reporting an adverse drug reaction.

Lotte Cornelissen1, Eugène van Puijenbroek, Kees van Grootheest.   

Abstract

OBJECTIVE: Aim of this study is to gain insight in experiences and expectations of general practitioners and specialist doctors regarding the feedback information of the Netherlands Pharmacovigilance Centre Lareb.
METHOD: A questionnaire survey was conducted among a random sample of 400 doctors, divided in general practitioners and specialist doctors. Within these groups, a difference was made between those who reported only once and those who are frequent reporters. A structured questionnaire consisted of 23 questions about expectations, experiences, the influence of feedback information and what the doctors would like to change in the feedback from Lareb. A comparison between the groups will give insight in what they think separately and how Lareb can seize on their wishes. KEY
FINDINGS: The response rate was 54.4% (n = 217) after one reminder. The respondents are satisfied with the feedback information and regarded the information of good quality. The expectations were higher on information about sources (significance 0.00, caused by specialist doctors who reported once) and co-medication (0.025 caused by all groups). The experiences of the four groups were also very positive. They all find the feedback information of Lareb reliable, scientifically well considered and to the point.
CONCLUSIONS: General practitioners and specialist doctors are satisfied about the follow-up information and they like to see the same format of information and communication in the future.

Mesh:

Year:  2008        PMID: 17987591     DOI: 10.1002/pds.1516

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.

Authors:  Ingrid Oosterhuis; Florence P A M van Hunsel; Eugène P van Puijenbroek
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

2.  Improving follow-up rates in spontaneous adverse drug reaction reporting: effectiveness of a targeted letter used by a regional centre in the UK.

Authors:  Christopher Anton; Anthony R Cox; Robin E Ferner
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Educational sessions in pharmacovigilance: What do the doctors think?

Authors:  Antonio Vallano; Consuelo Pedrós; Antonia Agustí; Gloria Cereza; Immaculada Danés; Cristina Aguilera; Josep Maria Arnau
Journal:  BMC Res Notes       Date:  2010-11-17

4.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

5.  Information and feedback to improve occupational physicians' reporting of occupational diseases: a randomised controlled trial.

Authors:  Annet F Lenderink; Dick Spreeuwers; Jac J L van der Klink; Frank J H van Dijk
Journal:  Int Arch Occup Environ Health       Date:  2009-10-15       Impact factor: 3.015

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.